Your browser doesn't support javascript.
loading
Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study).
Zeuschner, Philip; Hölters, Sebastian; Stöckle, Michael; Seliger, Barbara; Mueller, Anja; Bachmann, Hagen S; Grünwald, Viktor; Christoph, Daniel C; Stenzl, Arnulf; Grimm, Marc-Oliver; Brüning, Fabian; Goebell, Peter J; Augustin, Marinela; Roos, Frederik; Harde, Johanna; Benz-Rüd, Iris; Staehler, Michael; Junker, Kerstin.
Afiliação
  • Zeuschner P; Department of Urology and Pediatric Urology, Saarland University, Kirrberger Street, 66421 Homburg/Saar, Germany.
  • Hölters S; Department of Urology and Pediatric Urology, Saarland University, Kirrberger Street, 66421 Homburg/Saar, Germany.
  • Stöckle M; Department of Urology and Pediatric Urology, Saarland University, Kirrberger Street, 66421 Homburg/Saar, Germany.
  • Seliger B; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Universitätsplatz 10, 06108 Halle (Saale), Germany.
  • Mueller A; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Universitätsplatz 10, 06108 Halle (Saale), Germany.
  • Bachmann HS; Center for Biomedical Education and Research (ZBAF), Faculty of Health, Institute of Pharmacology and Toxicology, School of Medicine, Witten/Herdecke University, Stockumer Straße 10, 58453 Witten, Germany.
  • Grünwald V; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, University Hospital, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
  • Christoph DC; Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.
  • Stenzl A; Department of Medical Oncology, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.
  • Grimm MO; Department of Medical Oncology & Hematology, Evang. Kliniken Essen-Mitte, Evang. Huyssens-Stiftung Essen-Huttrop, Henricistrasse 92, 45136 Essen, Germany.
  • Brüning F; Department of Urology, University Hospital Tuebingen, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany.
  • Goebell PJ; Department of Urology, University Hospital Jena, Am Klinikum 1, 07747 Jena, Germany.
  • Augustin M; Department of Urology and Pediatric Urology, University Hospital Giessen and Marburg GmbH, Philipps-University Marburg, Baldingerstrasse, 35033 Marburg, Germany.
  • Roos F; Ambulatory Uro-Oncological Therapy Unit Erlangen (AURONTE), Department of Urology and Clinic for Haematology and Internistic Oncology, University Hospital Erlangen, Krankenhausstrasse 12, 91054 Erlangen, Germany.
  • Harde J; Department of Hematology and Oncology, Paracelsus Medical University, Prof.-Ernst-Nathan-Strasse 1, 90419 Nürnberg, Germany.
  • Benz-Rüd I; Department of Urology and Paediatric Urology, University Medical Center Mainz, Langenbeckstraße 1, 55131 Mainz, Germany.
  • Staehler M; Department of Urology, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
  • Junker K; Medical Department, iOMEDICO, Ellen-Gottlieb-Strasse 19, 70106 Freiburg im Breisgau, Germany.
Cancers (Basel) ; 13(11)2021 May 25.
Article em En | MEDLINE | ID: mdl-34070677
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha